Jonathan Lewis, MD
Enriched profileExecutive Chairman, Stealth Mode Biotech · Stealth Mode Biotech
Jonathan Lewis is Executive Chairman, Stealth Mode Biotech at Stealth Mode Biotech. ClinicalTrials.gov lists 14 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jonathan Lewis, MD, PHD, is Executive Chairman, Stealth Mode Biotech. The public record shows 113 publications with 14,048 citations (h-index 51), centered on Sarcoma, Breast Cancer, Lymphoma. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Sarcoma
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Study of Oral Darinaparsin in Patients With Advanced Solid Tumors
Sponsor: Alaunos Therapeutics
- Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Sponsor: Alaunos Therapeutics
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2023–2024. These are public disclosures, not judgments. The latest:
- TriSalus Life Sciences, Inc.Program year20243 payments$30,000openpaymentsdata.cms.gov ↗
- TriSalus Life Sciences, Inc.Program year202311 payments$84,750openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/PhD-Jonathan-J-Lewis-MD-79329569
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
curesarcoma.org/people/jonathan-lewis-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curesarcoma.org ↗ - Other
kristenanncarrfund.org/fellow/jonathan-lewis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kristenanncarrfund.org ↗ - Other
syncromune.com/2023/07/12/syncromune-inc-appoints-jonathan-lewis-m-d-ph-d-a-renowned-immune-therapy-pioneer-as-chief-medical-officer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →syncromune.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- PhD
Molecular and Cell Biology of Growth Factor Signal Transduction, University of the Witwatersrand / Yale School of Medicine
1990provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - MB
BCh (Bachelor of Medicine, Bachelor of Surgery), University of the Witwatersrand, Johannesburg
1982provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesarcoma.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Fellow
American College of Surgeons
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →24-7pressrelease.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →24-7pressrelease.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →24-7pressrelease.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →24-7pressrelease.com ↗
- Chief Strategy Officer
Syncromune, Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesarcoma.org ↗
Media & interviews
press, podcasts and appearances- Speaker
"The Future of Sarcoma Therapy - Development of Novel Agents," 2011 New England Sarcoma Symposium (YouTube video)
2011provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biospace.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
George Demetri, MD
Dana-Farber Cancer Institute; Professor of Medicine
Richard Gorlick, MD
The University of Texas MD Anderson Cancer Center
William Tap, MD
Memorial Sloan Kettering Cancer Center
Scott Schuetze, MD
University of Michigan Medical School